#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA618949	A	Time to reach maximum plasma concentration was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration	Mus musculus	1	ALA1146742	organism-based format	Scientific Literature
2.	ALA876724	A	Volume of distribution was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration	Mus musculus	1	ALA1146742	organism-based format	Scientific Literature
3.	ALA624543	A	Plasma clearance was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration	Canis lupus familiaris	1	ALA1146742	organism-based format	Scientific Literature
4.	ALA627878	A	Maximum plasma concentration of compound was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration	Canis lupus familiaris	1	ALA1146742	organism-based format	Scientific Literature
5.	ALA621687	A	Bioavailability was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration	Canis lupus familiaris	1	ALA1146742	organism-based format	Scientific Literature
6.	ALA623504	A	Plasma clearance was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration	Mus musculus	1	ALA1146742	organism-based format	Scientific Literature
7.	ALA623681	A	Time to reach maximum plasma concentration was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration	Canis lupus familiaris	1	ALA1146742	organism-based format	Scientific Literature
8.	ALA623413	A	Maximum plasma concentration of compound was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration	Mus musculus	1	ALA1146742	organism-based format	Scientific Literature
9.	ALA619552	A	Volume of distribution was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration	Canis lupus familiaris	1	ALA1146742	organism-based format	Scientific Literature
10.	ALA624341	A	Bioavailability was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration	Mus musculus	1	ALA1146742	organism-based format	Scientific Literature
11.	ALA618828	A	Half life was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration	Canis lupus familiaris	1	ALA1146742	organism-based format	Scientific Literature
12.	ALA627596	A	Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration	Mus musculus	1	ALA1146742	organism-based format	Scientific Literature
13.	ALA698859	F	Effective concentration to suppress interleukin-2 production was measured after 2.5 hours of oral administration in mice		4	ALA1146742	organism-based format	Scientific Literature
14.	ALA698860	F	Effective concentration to suppress interleukin-2 production was measured after 2.5 hours of oral administration in mice		4	ALA1146742	organism-based format	Scientific Literature
15.	ALA698861	F	Percent inhibition of interleukin-2 production by compound was measured after 18 hours of oral administration in mice		4	ALA1146742	organism-based format	Scientific Literature
16.	ALA698586	F	Percent inhibition of interleukin-2 production by compound was measured after 8 hours of oral administration in mice		4	ALA1146742	organism-based format	Scientific Literature
17.	ALA806434	B	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	Homo sapiens	7	ALA1146742	single protein format	Scientific Literature
18.	ALA814615	B	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	Homo sapiens	7	ALA1146742	single protein format	Scientific Literature
19.	ALA819966	F	Inhibition of anti-CD3 mAb induced inter leukein-2 production in human whole blood was evaluated	Homo sapiens	7	ALA1146742	organism-based format	Scientific Literature
20.	ALA816965	B	Inhibition of vascular endothelial growth factor receptor 2 activity with 1 mM ATP and biotinylated lck peptide	Homo sapiens	7	ALA1146742	single protein format	Scientific Literature